Liraglutide 3 mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma
Open accessAbstract
HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not.The documents may come from teaching and research institutions in France or abroad, or from public
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Most reports on GLP1-RA efficacy in patients with weight regain after bariatric surgery are limited to liraglutide and come from observational studies or case reports.
“Reports on the efficacy of GLP1-RAs in patients with weight regain after bariatric surgery are mostly limited to liraglutide in observational studies or case reports [9–20].”
The role of GLP1-RAs in treating weight regain after bariatric surgery is still not defined.
“Their role in the treatment of weight regain after bariatric surgery remains to be defined.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · see citing works
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163 · see citing works
Bretault, M., Boillot, A., Muzard, L., Poitou, C., Oppert, J., Barsamian, C., Gatta‐Cherifi, B., Muller, H. L., Weismann, D., Rottembourg, D., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4184 · Cited by 104 · see citing works
Self-citationLomenick, J. P., Buchowski, M. S., & Shoemaker, A. H. (2016) · Obesity · doi:10.1002/oby.21493 · Cited by 58 · see citing works
Ando, T., Haraguchi, A., Matsunaga, T., Natsuda, S., Yamasaki, H., Usa, T., & Kawakami, A. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1646 · Cited by 31 · see citing works
Simmons, J. H., Shoemaker, A. H., & Roth, C. L. (2012) · Hormone Research in Paediatrics · doi:10.1159/000339469 · Cited by 29 · see citing works
Bretault, M., Laroche, S., Lacorte, J., Barsamian, C., Polak, M., Raffin‐Sanson, M., Touraine, P. A., Bouillot, J., Czernichow, S., & Carette, C. (2016) · Obesity Surgery · doi:10.1007/s11695-015-1977-z · Cited by 15 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Jensen, A. B., Renström, F., Aczél, S., Folie, P., Biraima-Steinemann, M., Beuschlein, F., & Bilz, S. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06484-8 · Cited by 161 · see citing works
Semaglutide treatment of hypothalamic obesity – a real-life data study
Svendstrup, M., Rasmussen, A. K., Kistorp, C., Klose, M., & Andreassen, M. (2024) · Pituitary · doi:10.1007/s11102-024-01429-5 · Cited by 23 · see citing works
Lambert, F., Guillon, E., Gatta‐Cherifi, B., CranioGLP1_FORCE Group, Soula, H., Poitou, C., & Faucher, P. (2026) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.70216 · Cited by 12 · see citing works
- Authors
- Bretault, M., Carette, C., Zaharia, R., Vychnevskaia, K., Bouillot, J.-L., Czernichow, S., & Raffin-Sanson, M.-L.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Bretault, M.
- Venue
- Diabetes & Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 46
- Issue
- 6
- Pages
- 514-515
- ISSN
- 1262-3636 (ISSN-L)
- OpenAlex
- W2965721057
- Cited by
- 20
- References
- 7
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 5
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes & Metabolism (publishedVersion, other-oa)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
- Keywords
- liraglutide, hypothalamic obesity, craniopharyngioma, failed bariatric surgery, weight loss, GLP-1 receptor agonists
- MeSH terms
- Liraglutide, Craniopharyngioma, Humans, Hypothalamic Diseases, Male, Obesity, Pituitary Neoplasms, Postoperative Complications, Satiety Response, Weight Gain, Treatment Failure, Neurosurgical Procedures, Bariatric Surgery, Incretins, Young Adult, Binge-Eating Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
